Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Circulating tumor cells reveal early predictors of disease progression in patients with stage III NSCLC undergoing chemoradiation and immunotherapy

Cell Reports(2024)10.1016/j.celrep.2024.113687Source: DataRank Database

Circulating tumor cells reveal early predictors of disease progression in patients with stage III NSCLC undergoing chemoradiation and immunotherapy is a research paper published in Cell Reports (2024). On theSindex it has a DataRank of 0. It has been cited 15 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access15 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 2.90)OA: goldTopics (36)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Zeqi Niu ORCID,Sarah Owen ORCID,Madeline Grzesik,Abigail Radomski,Anna Kaehr

Live enrichment

PubMed:38261515 OpenAlex:https://openalex.org/W4391122666

NIH

Grant: 5-R33-CA-202867-02

NIH

Grant: U01CA210152

NIH

Grant: 1-R01-CA-208335-01-A1

NCI NIH HHS

Grant: R33 CA202867

NIBIB NIH HHS

Grant: T32 EB005582

NCI NIH HHS

Grant: R01 CA208335

FWCI

2.90

Citation Percentile

0.9%

Citation Trend

2024

2025

2026

goldLicense: cc-by-nc-nd

journalhttp://www.cell.com/article/S2211124724000159/pdf

publisherhttp://www.cell.com/article/S2211124724000159/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2211124724000159?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2211124724000159?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.celrep.2024.113687

Fields of Study

Cancer Cells and MetastasisCancer Immunotherapy and BiomarkersLung Cancer Research StudiesHumansCarcinoma, Non-Small-Cell LungNeoplastic Cells, CirculatingLung NeoplasmsImmunotherapyDisease ProgressionGraphite

MeSH Terms

Carcinoma, Non-Small-Cell LungGraphiteHumansImmunotherapyLung NeoplasmsNeoplastic Cells, CirculatingDisease Progression

Keywords

ImmunotherapyStage (stratigraphy)MedicineOncologyInternal medicineDiseaseCancer researchCancerBiologyLung cancerMicroarrayNSCLCChemoradiationCirculating Tumor CellsCancer BiomarkersCtcsLiquid BiopsyDurvalumabCp: Cancer

Sustainable Development Goals

SDG 0: Good health and well-being